Stéphanie Harel

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Laure Vincent, Luuk Gras, Patrice Ceballos, Jürgen Finke, Jakob Passweg, Stéphanie Harel, Laura Rosinol, Monique C Minnema, Raphael Teipel, Jaap A van Doesum, Mathias Hänel, Pascal Lenain, Carmen Botella-Garcia, Christian Koenecke, Sophie Ducastelle, Jaime Sanz Caballer, Wilfried Schroyens, Tsila Zukerman, Federico Monaco, Linda Koster, Liesbeth de Wreede, Patrick J Hayden, Stefan O Schönland, Ibrahim Yakoub Agha, Meral Beksac
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT. Bone marrow transplantation 57 (3) (2022)
Nicolas Vallet, Sylvie Chevret, Linda Feghoul, Lorea Aguinaga, Louise Bondeelle, Eleonore Kaphan, Rémi Bertinchamp, Juliette Soret, Camille Villesuzanne, Nathalie De Castro, Marie Sebert, David Boutboul, Etienne Lengline, Jean Jacques Tudesq, Florence Rabian, Lionel Ades, Alienor Xhaard, Roberta Di Blasi, Emmanuel Raffoux, Lionel Galicier, Jérôme Le Goff, Constance Delaugerre, Anne Bergeron, Stéphanie Harel, null null
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital. Blood cancer journal 11 (7) (2021)

Stéphanie Harel.css-eqlu8i{font-size:small;padding-left:4px;}